The best is the enemy of the good: Time for a biopsy-sparing approach for Helicobacter pylori diagnosis and treatment in children in the COVID-19 era?
作者信息
Monzani Alice, Lionetti Paolo, Rabbone Ivana, Lionetti Elena
机构信息
Division of Pediatrics, Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
Gastroenterology and Nutrition Unit, Department of Neurology, Pharmacology, Psychology and Child Health (NEUROFARBA), Meyer Children's Hospital, University of Florence, Florence, Italy.
出版信息
Helicobacter. 2021 Aug;26(4):e12826. doi: 10.1111/hel.12826. Epub 2021 May 28.
Abstract
摘要
相似文献
1
The best is the enemy of the good: Time for a biopsy-sparing approach for Helicobacter pylori diagnosis and treatment in children in the COVID-19 era?力求完美反成好事之敌：COVID-19 时代儿童幽门螺杆菌诊断与治疗采用活检保留方法的时候到了？
Helicobacter. 2021 Aug;26(4):e12826. doi: 10.1111/hel.12826. Epub 2021 May 28.
2
[Is upper gastro-intestinal endoscopy required for diagnosis and treatment of Helicobacter pylori infection in childhood? Pro and cons].
Arch Pediatr. 2003 Mar;10(3):256-9. doi: 10.1016/s0929-693x(03)00025-3.
3
[Helicobacter pylori infections in children].[儿童幽门螺杆菌感染]
Tijdschr Kindergeneeskd. 1992 Apr;60(2):35-9.
4
Helicobacter pylori infection and recurrent abdominal pain in children.儿童幽门螺杆菌感染与反复腹痛
J Trop Pediatr. 2003 Aug;49(4):250-2. doi: 10.1093/tropej/49.4.250.
5
Diagnose and treat Helicobacter pylori as any other infectious disease.
Am J Gastroenterol. 1996 Oct;91(10):2255-6.
6
Helicobacter pylori: diseases, tests and treatment.
Dig Liver Dis. 2001 Dec;33(9):788-94. doi: 10.1016/s1590-8658(01)80697-6.
7
Clarithromycin resistance and 23S rRNA gene point mutations of Helicobacter pylori infection in children.儿童幽门螺杆菌感染的克拉霉素耐药性及23S rRNA基因点突变
Turk J Pediatr. 2016;58(4):371-376. doi: 10.24953/turkjped.2016.04.004.
8
[Further standardize the diagnosis and treatment of infection in children].
Zhonghua Er Ke Za Zhi. 2023 Jul 2;61(7):577-579. doi: 10.3760/cma.j.cn112140-20230510-00326.
9
10
[Clinical importance of Helicobacter pylori infections in childhood].[儿童幽门螺杆菌感染的临床重要性]
Kinderarztl Prax. 1992 Dec;60(9-10):265-8.
引用本文的文献
1
H. Pylori Treatment in the COVID-19 Era. What Have We Learned So Far?新冠疫情时代的幽门螺杆菌治疗。我们目前了解到了什么？
Curr Gastroenterol Rep. 2024 Mar;26(3):86-91. doi: 10.1007/s11894-024-00922-y. Epub 2024 Feb 2.
本文引用的文献
1
Novel coronavirus disease (COVID-19) update on epidemiology, pathogenicity, clinical course and treatments.新型冠状病毒病（COVID-19）的流行病学、发病机制、临床病程和治疗的最新进展。
Int J Clin Pract. 2021 Apr;75(4):e13868. doi: 10.1111/ijcp.13868. Epub 2020 Dec 6.
2
ESPGHAN 'biopsy-sparing' guidelines for celiac disease in children with low antitransglutaminase during COVID-19.ESP-GHAN“活检豁免”指南：COVID-19 期间儿童抗转谷氨酰胺酶抗体低时的乳糜泻。
Eur J Gastroenterol Hepatol. 2020 Dec;32(12):1523-1526. doi: 10.1097/MEG.0000000000001924.
3
Helicobacter pylori Infection in Pediatric Patients Living in Europe: Results of the EuroPedHP Registry 2013 to 2016.儿童患者中幽门螺杆菌感染：来自 2013 年至 2016 年的欧洲儿科幽门螺杆菌注册研究结果。
J Pediatr Gastroenterol Nutr. 2020 Oct;71(4):476-483. doi: 10.1097/MPG.0000000000002816.
4
Changes in Pediatric Endoscopic Practice During the Coronavirus Disease 2019 Pandemic: Results From an International Survey.2019年冠状病毒病大流行期间儿科内镜操作的变化：一项国际调查结果
Gastroenterology. 2020 Oct;159(4):1547-1550. doi: 10.1053/j.gastro.2020.05.068. Epub 2020 May 30.
5
ESGE and ESGENA Position Statement on gastrointestinal endoscopy and the COVID-19 pandemic.ESGE 和 ESGENA 关于胃肠内镜和 COVID-19 大流行的立场声明。
Endoscopy. 2020 Jun;52(6):483-490. doi: 10.1055/a-1155-6229. Epub 2020 Apr 17.
6
Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016).欧洲儿科胃肠病、肝病和营养学会/北美儿科胃肠病、肝病和营养学会儿童及青少年幽门螺杆菌管理联合指南（2016年更新版）
J Pediatr Gastroenterol Nutr. 2017 Jun;64(6):991-1003. doi: 10.1097/MPG.0000000000001594.
Zotero 插件